BioElectronics Corporation Signs Major Distribution Agreement With OrthoPro, LLC For Podiatric Market

FREDERICK, Md., July 26 /PRNewswire-FirstCall/ -- BioElectronics Corporation, , announced today that they have signed a distribution agreement with OrthoPro, LLC, Salt Lake City, Utah, for distribution of the ActiPatch(TM) product. OrthoPro LLC will be the exclusive podiatry distributor in the Western States where their 50 sales representatives cover approximately one third of the United States market.

"We are very pleased to have OrthoPro, LLC and its affiliates as the cornerstone of our podiatry sales and distribution. Their dedicated group of professional sales representatives and affiliated podiatrists have a wealth of product knowledge and existing client relationships that will bode well for our future in podiatry," said Andrew J. Whelan, President, BioElectronics Corporation.

Craig Schelling, President of OrthoPro, LLC stated, "Our network of foot and ankle specialists have been extremely pleased with the results of ActiPatch on post operative surgery and inflammatory foot conditions."

About BioElectronics Corp.:

BioElectronics Corp. are the makers of ActiPatch(TM), a drug-free anti-inflammatory patch with an embedded battery operated microchip that delivers weeks of continuous pulsed therapy for less than a dollar a day. The unique ActiPatch delivery system, using patented technology, provides a cost-effective, patient friendly method to reduce soft tissue pain and swelling. For more information visit http://www.bioelectronicscorp.com

About OrthoPro, LLC:

OrthoPro, LLC is a leading manufacturer of foot implants and distributor of innovative foot and ankle products. http://www.orthoprollc.com

Safe Harbor Statement:

This news release contains forward-looking statements related to future growth and earnings opportunities. Such statements are based upon certain assumptions and assessments made by management of both companies in light of current conditions, expected future developments and other factors it believes to be appropriate. Actual results may differ as a result of factors over which the companies have no control.

BioElectronics Corporation

CONTACT: Andrew J. Whelan, President & CEO of BioElectronics Corporation,+1-301-644-3906, Fax: +1-301-644-3939, or info@bioelectronicscorp.com

MORE ON THIS TOPIC